For diabetes (Mounjaro brand): yes
Safety and limitations SGLT2 inhibitors are generally well tolerated but are associated with an increased risk of genital infections [103,104] and, rarely, euglycemic diabetic ketoacidosis [105-107]
This included a reduction in inflammatory cytokines, accelerated migration of corneal keratinocytes, and restoration of the epithelial barrier
These may be symptoms of gastroparesis (stomach paralysis)
In comparison, health plans are seeing the annual cost trend for weight loss drugs hit 40% to 50%, a spokesperson for the insurer said
Other secondary effects of GLP-1 RAs, such as gut microbiome shifts, may be asymptomatic and chronic with far-reaching physiologic potential